These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 9289506

  • 1. [Thyroid-stimulating hormone hypophyseal adenoma. A case report].
    Gannage MH, Maacaron C, Okais N, Halaby G.
    J Med Liban; 1997; 45(2):97-101. PubMed ID: 9289506
    [Abstract] [Full Text] [Related]

  • 2. Effect of octreotide acetate on thyrotropin-secreting adenoma: report of two cases and review of the literature.
    Yoenem A, Cakyr B, Azal O, Corakcy A, Kutlu M, Oezata M.
    Endocr Regul; 1999 Dec; 33(4):169-74. PubMed ID: 10700085
    [Abstract] [Full Text] [Related]

  • 3. [Monosymptomatic hyperthyroidism and TSH-producing adenoma: successful therapy with octreotide].
    Mayinger B, Axelos D, Pavel M, Hahn EG, Hensen J.
    Dtsch Med Wochenschr; 1999 Jan 29; 124(4):73-8. PubMed ID: 10071603
    [Abstract] [Full Text] [Related]

  • 4. Macro- and microadenoma of thyrotropin secreting pituitary tumors--two clinical cases.
    Hubalewska-Hola A, Fröss K, Kostecka-Matyja M, Sowa-Staszczak A, Szybiński Z, Huszno B, Ptak M.
    Przegl Lek; 2003 Jan 29; 60(11):768-71. PubMed ID: 15058054
    [Abstract] [Full Text] [Related]

  • 5. Long-term preoperative management of thyrotropin-secreting pituitary adenoma with octreotide.
    Iglesias P, Díez JJ.
    J Endocrinol Invest; 1998 Dec 29; 21(11):775-8. PubMed ID: 9972679
    [Abstract] [Full Text] [Related]

  • 6. Different responses to chronic somatostatin analogues in patients with central hyperthyroidism.
    Mannavola D, Persani L, Vannucchi G, Zanardelli M, Fugazzola L, Verga U, Facchetti M, Beck-Peccoz P.
    Clin Endocrinol (Oxf); 2005 Feb 29; 62(2):176-81. PubMed ID: 15670193
    [Abstract] [Full Text] [Related]

  • 7. TSH secreting pituitary adenoma.
    Jha S, Kumar S.
    J Assoc Physicians India; 2009 Jul 29; 57():537-9. PubMed ID: 20329419
    [Abstract] [Full Text] [Related]

  • 8. Thyrotropin-secreting pituitary adenomas: biological and molecular features, diagnosis and therapy.
    Losa M, Fortunato M, Molteni L, Peretti E, Mortini P.
    Minerva Endocrinol; 2008 Dec 29; 33(4):329-40. PubMed ID: 18923369
    [Abstract] [Full Text] [Related]

  • 9. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
    Teramoto A, Sanno N, Tahara S, Osamura YR.
    Acta Neuropathol; 2004 Aug 29; 108(2):147-53. PubMed ID: 15185102
    [Abstract] [Full Text] [Related]

  • 10. Thyrotropin secreting pituitary adenoma accompanying a silent somatotropinoma.
    Berker D, Isik S, Aydin Y, Tutuncu Y, Akdemir G, Ozcan HN, Guler S.
    Turk Neurosurg; 2011 Aug 29; 21(3):403-7. PubMed ID: 21845579
    [Abstract] [Full Text] [Related]

  • 11. [Thyrotropin-secreting pituitary adenomas].
    Caron P.
    Presse Med; 2009 Jan 29; 38(1):107-11. PubMed ID: 18980829
    [Abstract] [Full Text] [Related]

  • 12. Thyrotropin secreting pituitary adenoma effectively treated with octreotide.
    Fukuda T, Yokoyama N, Tamai M, Imaizumi M, Kimura H, Tominaga T, Ashizawa K, Kiriyama T, Yoshimine H, Ohishi K, Eguchi K.
    Intern Med; 1998 Dec 29; 37(12):1027-30. PubMed ID: 9932634
    [Abstract] [Full Text] [Related]

  • 13. Clinical characteristics of patients with thyrotropin-secreting pituitary adenoma.
    Wu YY, Chang HY, Lin JD, Chen KW, Huang YY, Jung SM.
    J Formos Med Assoc; 2003 Mar 29; 102(3):164-71. PubMed ID: 12783133
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of the long-acting octreotide formulation in patients with thyroid-stimulating hormone-secreting pituitary adenomas after incomplete surgery and octreotide treatment failure.
    Zhang CF, Liang D, Zhong LY.
    Chin Med J (Engl); 2012 Aug 29; 125(15):2758-63. PubMed ID: 22931988
    [Abstract] [Full Text] [Related]

  • 15. [Hypophyseal thyrotropin adenomas at Yaounde (Cameroon). Analysis of two case reports: improvement with somatostatin analogue (SMS 201-995)].
    Nouedoui C, Moukouri E, Juimo AG, Dongmo L, Zok FD, Tapko JB, Muna WF.
    Tunis Med; 1999 Mar 29; 77(3):154-8. PubMed ID: 10392035
    [No Abstract] [Full Text] [Related]

  • 16. Thyroid-stimulating hormone pituitary adenomas.
    Clarke MJ, Erickson D, Castro MR, Atkinson JL.
    J Neurosurg; 2008 Jul 29; 109(1):17-22. PubMed ID: 18590428
    [Abstract] [Full Text] [Related]

  • 17. Preoperative long-acting octreotide treatment for invasive thyrotropin-secreting pituitary macroadenoma after previous radioiodine thyroid ablation.
    Gruszka A, Zielinski GM, Kunert-Radek J.
    J Clin Neurosci; 2014 Feb 29; 21(2):340-2. PubMed ID: 23958483
    [Abstract] [Full Text] [Related]

  • 18. Thyrotropin-secreting pituitary tumors in hyper- and hypothyroidism.
    Beck-Peccoz P, Persani L, Asteria C, Cortelazzi D, Borgato S, Mannavola D, Romoli R.
    Acta Med Austriaca; 1996 Feb 29; 23(1-2):41-6. PubMed ID: 8767513
    [Abstract] [Full Text] [Related]

  • 19. [Effect of long-term treatment with octreotide-lar in a TSH-secreting pituitary macroadenoma and secondary hyperthyroidism].
    Del Monte P, Bernasconi D, Ruelle A, Marugo A, Marugo M, Torre R.
    Minerva Endocrinol; 2005 Jun 29; 30(2):95-9. PubMed ID: 15988405
    [Abstract] [Full Text] [Related]

  • 20. Hyperthyroidism caused by an ectopic thyrotropin-secreting tumor of the nasopharynx: a case report and review of the literature.
    Tong A, Xia W, Qi F, Jin Z, Yang D, Zhang Z, Li F, Xing X, Lian X.
    Thyroid; 2013 Sep 29; 23(9):1172-7. PubMed ID: 23402621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.